Text this: WCN25-625 ASSESSING RENAL FUNCTION IN PATIENTS UNDERGOING TARGETED CANCER THERAPIES: THE ROLE OF CYSTATIN C IN PALBOCICLIB-INDUCED SERUM CREATININE ELEVATION